A detailed history of Foundation Resource Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Foundation Resource Management Inc holds 127,756 shares of MRK stock, worth $14.5 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares
127,756
Previous 128,818 0.82%
Holding current value
$14.5 Million
Previous $17 Million 6.95%
% of portfolio
2.53%
Previous 2.67%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$123.8 - $132.96 $131,475 - $141,203
-1,062 Reduced 0.82%
127,756 $15.8 Million
Q1 2024

Apr 11, 2024

SELL
$113.24 - $131.95 $7.68 Million - $8.95 Million
-67,805 Reduced 34.48%
128,818 $17 Million
Q4 2023

Jan 10, 2024

SELL
$100.18 - $109.02 $320,576 - $348,864
-3,200 Reduced 1.6%
196,623 $21.4 Million
Q3 2023

Oct 10, 2023

SELL
$102.95 - $114.33 $375,252 - $416,732
-3,645 Reduced 1.79%
199,823 $20.6 Million
Q2 2023

Jul 12, 2023

SELL
$108.61 - $118.38 $71,139 - $77,538
-655 Reduced 0.32%
203,468 $23.5 Million
Q1 2023

Apr 11, 2023

SELL
$102.94 - $114.86 $131,866 - $147,135
-1,281 Reduced 0.62%
204,123 $21.7 Million
Q4 2022

Jan 12, 2023

SELL
$87.44 - $112.11 $25,445 - $32,624
-291 Reduced 0.14%
205,404 $22.8 Million
Q3 2022

Oct 13, 2022

BUY
$84.53 - $94.96 $204,478 - $229,708
2,419 Added 1.19%
205,695 $17.7 Million
Q2 2022

Jul 15, 2022

SELL
$83.49 - $94.64 $1.01 Million - $1.14 Million
-12,090 Reduced 5.61%
203,276 $18.5 Million
Q1 2022

Apr 12, 2022

SELL
$73.51 - $82.4 $18,230 - $20,435
-248 Reduced 0.12%
215,366 $17.7 Million
Q4 2021

Jan 21, 2022

SELL
$72.28 - $90.54 $15.6 Million - $19.5 Million
-215,614 Reduced 50.0%
215,614 $16.5 Million
Q4 2021

Jan 12, 2022

BUY
$72.28 - $90.54 $15.3 Million - $19.1 Million
211,474 Added 96.23%
431,228 $33 Million
Q3 2021

Oct 12, 2021

SELL
$71.68 - $78.83 $64,512 - $70,947
-900 Reduced 0.41%
219,754 $16.5 Million
Q2 2021

Jul 13, 2021

SELL
$70.31 - $77.77 $463,975 - $513,204
-6,599 Reduced 2.9%
220,654 $17.2 Million
Q1 2021

Apr 08, 2021

SELL
$68.86 - $81.11 $242,731 - $285,912
-3,525 Reduced 1.53%
227,253 $17.5 Million
Q4 2020

Jan 13, 2021

SELL
$71.77 - $79.65 $264,113 - $293,112
-3,680 Reduced 1.57%
230,778 $18.9 Million
Q3 2020

Oct 07, 2020

SELL
$73.18 - $82.95 $522,651 - $592,428
-7,142 Reduced 2.96%
234,458 $19.4 Million
Q2 2020

Jul 08, 2020

SELL
$70.42 - $80.13 $440,617 - $501,373
-6,257 Reduced 2.52%
241,600 $18.7 Million
Q1 2020

Apr 08, 2020

SELL
$63.36 - $87.82 $4.3 Million - $5.95 Million
-67,809 Reduced 21.48%
247,857 $19.1 Million
Q4 2019

Jan 08, 2020

SELL
$77.58 - $87.54 $778,670 - $878,638
-10,037 Reduced 3.08%
315,666 $28.7 Million
Q3 2019

Oct 03, 2019

SELL
$76.08 - $82.93 $382,378 - $416,806
-5,026 Reduced 1.52%
325,703 $27.4 Million
Q2 2019

Jul 10, 2019

SELL
$69.84 - $81.59 $138,213 - $161,466
-1,979 Reduced 0.59%
330,729 $27.7 Million
Q1 2019

Apr 11, 2019

SELL
$69.58 - $79.36 $844,492 - $963,192
-12,137 Reduced 3.52%
332,708 $27.7 Million
Q4 2018

Jan 17, 2019

SELL
$65.24 - $75.71 $191,479 - $222,208
-2,935 Reduced 0.84%
344,845 $26.4 Million
Q3 2018

Oct 02, 2018

SELL
$57.69 - $67.84 $7.41 Million - $8.72 Million
-128,480 Reduced 26.98%
347,780 $24.7 Million
Q2 2018

Jul 11, 2018

SELL
$50.83 - $59.72 $59,623 - $70,051
-1,173 Reduced 0.25%
476,260 $28.9 Million
Q1 2018

Apr 19, 2018

SELL
$50.96 - $59.23 $6.09 Million - $7.08 Million
-119,521 Reduced 20.02%
477,433 $26 Million
Q4 2017

Jan 10, 2018

SELL
$51.62 - $61.64 $386,891 - $461,991
-7,495 Reduced 1.24%
596,954 $33.6 Million
Q3 2017

Oct 11, 2017

BUY
$58.67 - $63.13 $35.5 Million - $38.2 Million
604,449
604,449 $38.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Foundation Resource Management Inc Portfolio

Follow Foundation Resource Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foundation Resource Management Inc with notifications on news.